Origin Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Origin Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,100	Closed	-$333K	–	176
2016 Q4	$333K	Hold	3,100	–	–	0.02%	126
2016 Q3	$386K	Hold	3,100	–	–	0.02%	106
2016 Q2	$330K	Hold	3,100	–	–	0.02%	104
2016 Q1	$355K	Hold	3,100	–	–	0.02%	97
2015 Q4	$442K	Hold	3,100	–	–	0.04%	90
2015 Q3	$278K	Hold	3,100	–	–	0.02%	93
2015 Q2	$357K	Hold	3,100	–	–	0.03%	92
2015 Q1	$296K	Hold	3,100	–	–	0.02%	97
2014 Q4	$208K	Buy	+3,100	New	+$192K	0.02%	105

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Origin Asset Management's CBPO Position: Q1 2017 in Review

Origin Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 3,100 shares — an estimated $333K sold.

Origin Asset Management first reported a position in CBPO in Q4 2014 and held it in 9 quarters. The position peaked at $442K in Q4 2015. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

Origin Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
Origin Asset Management sold 3,100 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $333K.
Origin Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q4 2014 and held it in 9 quarters.
Origin Asset Management's China Biologic Products Holdings, Inc. position peaked at $442K in Q4 2015.
137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on Origin Asset Management's 13F filing for Q1 2017, filed 11 May 2017.